检验医学与临床
檢驗醫學與臨床
검험의학여림상
JOURNAL OF LABORATORY MEDICINE AND CLINICAL SCIENCES
2014年
15期
2073-2075
,共3页
高小文%孙安平%陈建华%乔永峰%孔花娟%李玲贤%陈皎%郑荣%李雄海
高小文%孫安平%陳建華%喬永峰%孔花娟%李玲賢%陳皎%鄭榮%李雄海
고소문%손안평%진건화%교영봉%공화연%리령현%진교%정영%리웅해
乳胶增强免疫比浊法%髓过氧化物酶%OLYMPUS AU2700
乳膠增彊免疫比濁法%髓過氧化物酶%OLYMPUS AU2700
유효증강면역비탁법%수과양화물매%OLYMPUS AU2700
latex-enhanced immunoturbidimetry%myeloperoxidase%OLYMPUS AU2700
目的:评价血浆髓过氧化物酶(MPO)乳胶增强免疫比浊法试剂盒在AU2700全自动生化分析仪使用的性能验证。方法根据美国临床实验室标准化委员会(NCCLS)的评价方案对北京九强公司生产的乳胶增强免疫比浊法髓过氧化物酶测定试剂盒进行了回收试验、干扰试验、临床可报告范围及精密度验证。结果北京九强生产的MPO乳胶增强免疫比浊法试剂盒的两个浓度水平质控品的实验室精密度CV为8.9%;回收率95.7%~108.3%。线性评价的相关系数r=0.997,线性回归方程为Y=1.033X-25.092;干扰试验中不同程度的标本溶血均对测定MPO造成严重干扰。抗坏血酸6.3~100mg/L,三酰甘油小于7.8mmol/L内无明显干扰,相对偏差小于10%,三酰甘油浓度大于7.8mmol/L对试验有明显干扰,相对偏差为11.5%~11.9%。结论九强公司在国内首次推出的髓过氧化物酶(MPO)乳胶增强免疫比浊法试剂盒在抗干扰、线性、正确度及精密度等方面的性能达到临床需求,值得在临床心脑血管危险因子检测中推广应用。
目的:評價血漿髓過氧化物酶(MPO)乳膠增彊免疫比濁法試劑盒在AU2700全自動生化分析儀使用的性能驗證。方法根據美國臨床實驗室標準化委員會(NCCLS)的評價方案對北京九彊公司生產的乳膠增彊免疫比濁法髓過氧化物酶測定試劑盒進行瞭迴收試驗、榦擾試驗、臨床可報告範圍及精密度驗證。結果北京九彊生產的MPO乳膠增彊免疫比濁法試劑盒的兩箇濃度水平質控品的實驗室精密度CV為8.9%;迴收率95.7%~108.3%。線性評價的相關繫數r=0.997,線性迴歸方程為Y=1.033X-25.092;榦擾試驗中不同程度的標本溶血均對測定MPO造成嚴重榦擾。抗壞血痠6.3~100mg/L,三酰甘油小于7.8mmol/L內無明顯榦擾,相對偏差小于10%,三酰甘油濃度大于7.8mmol/L對試驗有明顯榦擾,相對偏差為11.5%~11.9%。結論九彊公司在國內首次推齣的髓過氧化物酶(MPO)乳膠增彊免疫比濁法試劑盒在抗榦擾、線性、正確度及精密度等方麵的性能達到臨床需求,值得在臨床心腦血管危險因子檢測中推廣應用。
목적:평개혈장수과양화물매(MPO)유효증강면역비탁법시제합재AU2700전자동생화분석의사용적성능험증。방법근거미국림상실험실표준화위원회(NCCLS)적평개방안대북경구강공사생산적유효증강면역비탁법수과양화물매측정시제합진행료회수시험、간우시험、림상가보고범위급정밀도험증。결과북경구강생산적MPO유효증강면역비탁법시제합적량개농도수평질공품적실험실정밀도CV위8.9%;회수솔95.7%~108.3%。선성평개적상관계수r=0.997,선성회귀방정위Y=1.033X-25.092;간우시험중불동정도적표본용혈균대측정MPO조성엄중간우。항배혈산6.3~100mg/L,삼선감유소우7.8mmol/L내무명현간우,상대편차소우10%,삼선감유농도대우7.8mmol/L대시험유명현간우,상대편차위11.5%~11.9%。결론구강공사재국내수차추출적수과양화물매(MPO)유효증강면역비탁법시제합재항간우、선성、정학도급정밀도등방면적성능체도림상수구,치득재림상심뇌혈관위험인자검측중추엄응용。
Objective To evaluate the performance verification of method of detecting myeloperoxidase with immunoturbidimetry of latex-enhanced on the analyser OLYMPUS AU2700 .Methods According to evaluation scheme of National Committee for Clinical Laboratory Standards (NCCLS ) ,carried out recovery test ,interference test ,clinicalreportablerange and precision verification for myeloperoxidase with immunoturbidimetry of latex-en-hanced determination kit ,which is produced by Beijing Strong Biotechnologies ,Inc .Results The coefficient of varia-tion of two levels of quality control products produced by Beijing Strong Biotechnologies ,Inc is 8 .9 % ;percent re-covery is between 95 .7% and 108 .3% .In the regression analysis ,correlation coefficient is 0 .997 ,equation of linear regression is Y=1 .033X -25 .092 .Different degrees of hemolysis caused serious interference in the test of MPO . When vitamin C is between6 .3 mg/L and 100 mg/L ,triglycerides is less than 7 .8 mmol/L ,no significant interference is found ,relative deviation is less than 10% .When triglycerides is more than 7 .8 mmol/L ,had serious interference , relative deviation is between 11 .5% and 11 .9% .Conclusion Myeloperoxidase with immunoturbidimetry of latex-en-hanced determination kit produced by Beijing Strong Biotechnologies ,Inc is to achieve the clinical Standard in terms of anti-interference ,linearity ,accuracy and precision ,it is worthy of popularization and application in the detection of clinical cardiovascular risk factors .